Tardive dyskinesia, a distressing neurological disorder marked by involuntary movements, often arises from prolonged use of psychiatric medications. Austedo, a targeted treatment, offers significant relief by reducing these symptoms and improving patients’ quality of life. Discover how Austedo’s efficacy, safety, and compatibility with mental health medications provide a comprehensive approach to managing this challenging condition.
Understanding Tardive Dyskinesia and Its Impact
Tardive dyskinesia (TD) is a neurological disorder characterized by involuntary, repetitive body movements, often affecting the face, tongue, and limbs. It is commonly associated with long-term use of certain psychiatric medications, particularly antipsychotics. These movements can be distressing and significantly impact a person’s quality of life, making effective management crucial. Early diagnosis and treatment are essential to mitigate the symptoms and improve daily functioning (source).
How Austedo Alleviates Tardive Dyskinesia Symptoms
Austedo (deutetrabenazine) is a medication specifically approved for the treatment of tardive dyskinesia. It works by inhibiting the vesicular monoamine transporter 2 (VMAT2), which helps regulate dopamine levels in the brain. This mechanism reduces abnormal involuntary movements associated with TD. Clinical studies have shown that Austedo can significantly reduce TD symptoms, with over 70% of patients experiencing a reduction in their Abnormal Involuntary Movement Scale (AIMS) score by Week 12 (source).
Long-term Efficacy and Safety of Austedo
Long-term studies have demonstrated the sustained efficacy of Austedo in managing TD symptoms. A three-year open-label study confirmed consistent movement improvement and a well-established safety profile. Nearly 96% of patients continued taking Austedo without needing to reduce their dose due to side effects, and a high level of patient satisfaction was reported (source). However, it is important to monitor for potential side effects, such as depression and suicidal thoughts, especially in individuals with Huntington’s disease (source).
Compatibility with Mental Health Medications
Austedo can be taken alongside most mental health medications, providing flexibility for patients managing multiple conditions. This compatibility is crucial for individuals who require ongoing psychiatric treatment while addressing TD symptoms. Studies have shown that 85% of patients taking Austedo alongside their mental health medications experienced stable or improved mental health conditions (source).
Patient Support and Resources
Teva Shared Solutions® offers comprehensive support for patients prescribed Austedo XR. This program includes financial assistance, insurance navigation, and nurse support to ensure patients can start and maintain their treatment effectively. More than 90% of patients pay $10 or less per month for Austedo XR, thanks to financial assistance options provided by Shared Solutions (source).
Why You Should Learn More About Austedo and Tardive Dyskinesia Today
Understanding the impact of tardive dyskinesia and the role of Austedo in managing its symptoms is crucial for patients and healthcare providers alike. With its proven efficacy and safety profile, Austedo offers hope for those affected by this challenging condition. By exploring available resources and support programs, patients can better navigate their treatment journey and improve their quality of life. Staying informed about the latest developments in TD management can empower individuals to make informed decisions about their health and well-being.